ABOUT US_Shanghai Genesense Technology Inc.

GeneSense was founded in 2017 by Dr. Yan Mei, an expert in both NGS sequencing and CIS chip development. GeneSense boasts a core technology R&D team composed of top talents in the industry. GeneSense is dedicated to pioneering gene sequencing technologies, Xinxiang Biotech is committed to contributing new insights to the exploration of genetic information.

Employee

R&D proportion

Master

Professional talent, high-tech enterprise with global layout

Global layout

Starting from its center in Hong Kong, China, GeneSense has grown into a global enterprise with R&D and business centers in Shanghai, China, Shenzhen, China and many other regions around the world.

Shanghai

Address:

Zhangjiang Hi-Tech, Shanghai,

Tel: 021-50931201

Email: Sales@gene-sense.com

Hongkong

Address:

Building 1E, Hong Kong Science Park

Tel: +852 3460 5372

Email: Sales@gene-sense.com

Shenzhen

Address:

Loop Shenzhen-Hong Kong Science and Technology Innovation Cooperation Park

Tel: 4008 206 806

Email: Sales@gene-sense.com

Milestone

2023

· GeneSense successfully applied for nearly 40 patents in China and the United States

· Officially released the gene sequencing platform StarSeq100 and started the commercialization process

2022

· GeneSense built a 3000m2 GMP production plant in Pujiang, Shanghai

· StarSeq100 Beta completed

2021

· GeneSense Shenzhen set up

· GeneSense successfully developed an instrument prototype with independent intellectual property rights

2020

StarSeq 100 V1 (prototype) completed

2019

The core technology of GeneSense was successfully developed

2018

Microscope system developed successfully

2017

GeneSense set up

Patents and honors

Our Vision

Accessible to everyone · Foundable everywhere

Promote gene sequencing technology to reach more application boundaries, bring intelligent and high-performance NGS sequencing technology closer to everyone, and empower all the industries

Everybody · Everywhere · Everytime